Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Spondyloarthritis Biologics 'Game-Changing' for Juvenile Disease

(MedPage Today) -- Researchers continue to lay the groundwork for expanding treatment in juvenile spondyloarthritis (SpA), borrowing from advances in disease-modifying anti-rheumatic drugs (DMARDs) in adults. Earlier this year, the interleukin...

Spondyloarthritis Biologics 'Game-Changing' for Juvenile Disease

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Monday 2 November →